Skip to content

Metabonomics combined with image recognition to explore artificial intelligence quantitative methodologies for macroscopic and microscopic differentiation of urine in chronic heart failure with cold and heat syndrome

Metabonomics combined with image recognition to explore artificial intelligence quantitative methodologies for macroscopic and microscopic differentiation of urine in chronic heart failure with cold and heat syndrome

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2000029146
Enrollment
Unknown
Registered
2020-01-16
Start date
2020-01-01
Completion date
Unknown
Last updated
2020-01-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic heart failure, type 2 heart and kidney syndrome

Interventions

Sponsors

Beijing University of Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
20 Years to 80 Years

Inclusion criteria

Inclusion criteria: Selection criteria for chronic heart failure cases: 1. It is consistent with the diagnosis of chronic heart failure, and is currently in the stages of chronic heart failure B, C, D, and there is no renal impairment; 2. NYHA grade I ~ IV for cardiac function; 3. Aged 50-70 years old; 4. Sign informed consent. Selection criteria for type 2 heart and kidney syndrome cases: 1. Meet the diagnosis of type 2 heart and kidney syndrome, CKD is in stage 1 ~ 4; 2. NYHA grade I ~ IV for cardiac function; 3. Aged 50-70 years old; 4. Sign informed consent.

Exclusion criteria

Exclusion criteria: 1. Patients with severe valvular disease, pericardial disease, congenital heart disease, unstable angina pectoris, acute myocardial infarction (within 4 weeks), severe arrhythmia accompanied by hemodynamic changes or who have received coronary revascularization in the past 4 weeks; 2. Complicated with chronic obstructive pulmonary disease, pulmonary heart disease, pulmonary hypertension caused by acute and chronic pulmonary embolism, and stroke within the past six months; 3. Complicated with severe liver dysfunction (liver function index value> 2 times normal value), CKD5 stage (GFR 5.5mmol / L), malignant tumor, Diabetes with severe complications, hyperthyroidism, hypothyroidism and other serious endocrine diseases or other uncontrollable systemic diseases; 4. Pregnant or lactating women; patients with mental and infectious diseases; acute and chronic urinary tract infections; 5. Participants in other researchers within the past month; 6. At the discretion of the investigator, the patient could not complete the study or did not comply with the requirements of the study (due to management or other reasons).

Design outcomes

Primary

MeasureTime frame
Urine Routine Test;

Countries

China

Contacts

Public ContactZhao Huihui

Beijing University of Traditional Chinese Medicine

hh686@126.com+86 010 64286010

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026